Glucagon and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Glucagon (glucagon hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Cataplexy.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Glucagon. It is created by eHealthMe based on reports of 4,289 people who have side effects when taking Glucagon from the FDA, and is updated regularly.

What is Glucagon?

Glucagon has active ingredients of glucagon hydrochloride. eHealthMe is studying from 4,297 Glucagon users. Check the latest studies of Glucagon.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,750 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

On Aug, 06, 2026

4,289 people reported to have side effects when taking Glucagon.
Among them, 20 people (0.47%) have Hypersensitivity.

Among these 20 people:

How long have people been on Glucagon when they have Hypersensitivity? *

What is the gender of people who have Hypersensitivity when taking Glucagon? *

female: 89.47 %
male: 10.53 %

What is the age of people who have Hypersensitivity when taking Glucagon? *

What are other drugs people take besides Glucagon? *

What are other side effects people have besides Hypersensitivity? *

Dyspnea (difficult or laboured breathing): 7 people, 35.00%
Chest Pain: 5 people, 25.00%
Heart Rate Decreased: 4 people, 20.00%
Hypotension (abnormally low blood pressure): 4 people, 20.00%
Sinusitis (inflammation of sinus): 4 people, 20.00%
Fatigue (feeling of tiredness): 4 people, 20.00%
Headache (pain in head): 4 people, 20.00%
Insomnia (sleeplessness): 4 people, 20.00%
Impaired Healing: 4 people, 20.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 15.00%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 15.00%
Hypoglycemia (low blood sugar): 3 people, 15.00%
Cystic Fibrosis (disease of the secretary glands): 3 people, 15.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 15.00%
Type 1 Diabetes: 2 people, 10.00%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 10.00%
Thyroid Diseases: 1 person, 5.00%
Sleep Disorder: 1 person, 5.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 5.00%
Panic Disorder: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Glucagon and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glucagon:

Glucagon (4,297 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

Browse all side effects of Glucagon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,750 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,913 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glucagon hydrochloride (the active ingredients of Glucagon) and Glucagon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.